CDH13 and type 1 diabetes mellitus: Proposed factors influencing adiponectin include insulin signaling impairments, as observed among patients with Type 1 Diabetes [71], and in animal studies that found dependence of adiponectin expression on T-cadherin and glycoprotein levels [72, 73].